EGLU

EGLU ((2S)-α-ethylglutamic acid ) is a drug that is used in neuroscience research. It was one of the first compounds found that acts as a selective antagonist for the group II metabotropic glutamate receptors (mGluR_2/3), and so has been useful in the characterization and study of this receptor subfamily.^{[1][2][3][4][5][6][7]}

EGLU

Identifiers
IUPAC name (2S)-2-Amino-2-ethylpentanedioic acid
CAS Number	170984-72-2 Y[yes]
PubChem CID	5311079
IUPHAR/BPS	1400
ChemSpider	4470613 N
CompTox Dashboard (EPA)	DTXSID50415504
Chemical and physical data
Formula	C7H13NO4
Molar mass	175.184 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C(O)CC[C@](N)(C(=O)O)CC
InChI InChI=1S/C7H13NO4/c1-2-7(8,6(11)12)4-3-5(9)10/h2-4,8H2,1H3,(H,9,10)(H,11,12)/t7-/m0/s1 N Key:QFYBYZLHPIALCZ-ZETCQYMHSA-N N
NY (what is this?)  (verify)